Combining common genetic variants and non-genetic risk factors to predict risk of cutaneous melanoma

scientific article published in 2018

Combining common genetic variants and non-genetic risk factors to predict risk of cutaneous melanoma is …
instance of (P31):
scholarly articleQ13442814
meta-analysisQ815382

External links are
P356DOI10.1093/HMG/DDY282
P932PMC publication ID6240742
P698PubMed publication ID30060076

P50authorRuth PfeifferQ90909936
Stephen ChanockQ27662321
Maria Teresa LandiQ28606990
Evangelos EvangelouQ30436575
Monica RodolfoQ37376562
Stuart MacgregorQ42711014
Eduardo NagoreQ51812182
Matthew H LawQ56420235
Lorenza PastorinoQ56435904
Anne E CustQ56923556
P2093author name stringFangyi Gu
D Timothy Bishop
Jianxin Shi
Arcangela De Nicolo
Xing Hua
Susana Puig
Alexander J Stratigos
Kevin M Brown
Ketty Peris
Paola Ghiorzo
Curt T DellaValle
Donato Calista
Cristina Pellegrini
Maria Concetta Fargnoli
Tongwu Zhang
Chiara Menin
Ting-Huei Chen
Melanoma Meta-Analysis Consortium
MelaNostrum Consortium
Mark I Iles
P2860cites workRisk of cutaneous melanoma associated with a family history of the diseaseQ58283406
Epidemiology, etiology, and control of melanomaQ74302576
Development of an individual score for melanoma riskQ83601587
POT1 loss-of-function variants predispose to familial melanomaQ24563091
Germline mutations in BAP1 predispose to melanocytic tumorsQ24594891
Melanesian blond hair is caused by an amino acid change in TYRP1Q24623400
PLINK: a tool set for whole-genome association and population-based linkage analysesQ24677407
Common polygenic variation contributes to risk of schizophrenia and bipolar disorderQ28250609
Germline mutations in the p16INK4a binding domain of CDK4 in familial melanomaQ28270834
Winner's Curse Correction and Variable Thresholding Improve Performance of Polygenic Risk Modeling Based on Genome-Wide Association Study Summary-Level DataQ28917124
TERT promoter mutations in familial and sporadic melanomaQ29614920
pROC: an open-source package for R and S+ to analyze and compare ROC curvesQ30050695
Development and validation of a melanoma risk score based on pooled data from 16 case-control studiesQ30899396
Individual risk of cutaneous melanoma in New Zealand: developing a clinical prediction aidQ33685033
Rare missense variants in POT1 predispose to familial cutaneous malignant melanomaQ33751971
Familial Risk and Heritability of Cancer Among Twins in Nordic CountriesQ33874409
IRF4 variants have age-specific effects on nevus count and predispose to melanomaQ33960494
Causal effects in clinical and epidemiological studies via potential outcomes: concepts and analytical approachesQ33960730
Power and predictive accuracy of polygenic risk scores.Q34337027
A prognostic model for predicting 10-year survival in patients with primary melanoma. The Pigmented Lesion GroupQ34388378
Replication and predictive value of SNPs associated with melanoma and pigmentation traits in a Southern European case-control studyQ34581022
Testing calibration of risk models at extremes of disease riskQ34678258
Most common 'sporadic' cancers have a significant germline genetic componentQ34736858
Genome-wide association study identifies variants at 9p21 and 22q13 associated with development of cutaneous neviQ34831505
Joint effect of multiple common SNPs predicts melanoma susceptibilityQ35083167
Nonsense mutations in the shelterin complex genes ACD and TERF2IP in familial melanomaQ35102528
Indoor tanning and the MC1R genotype: risk prediction for basal cell carcinoma risk in young people.Q35652527
Identifying Persons at Highest Risk of Melanoma Using Self-Assessed Risk FactorsQ35655735
A novel recurrent mutation in MITF predisposes to familial and sporadic melanomaQ35699278
Genetics of skin color variation in Europeans: genome-wide association studies with functional follow-upQ35829596
Genome-wide meta-analysis identifies five new susceptibility loci for cutaneous malignant melanomaQ36019187
Modeling Linkage Disequilibrium Increases Accuracy of Polygenic Risk ScoresQ36133352
Incidence of basal cell and squamous cell carcinomas in a population younger than 40 yearsQ36224045
Estimating the population attributable risk for multiple risk factors using case-control dataQ36499362
Prediction of breast cancer risk based on profiling with common genetic variantsQ36583004
Features associated with germline CDKN2A mutations: a GenoMEL study of melanoma-prone families from three continentsQ37004819
Projecting the performance of risk prediction based on polygenic analyses of genome-wide association studiesQ37059182
PARKIN Inactivation Links Parkinson's Disease to MelanomaQ38810658
Personal risk-factor chart for cutaneous melanomaQ39200858
Prediction of Melanoma Risk in a Southern European Population Based on a Weighted Genetic Risk ScoreQ40833067
Independent validation of six melanoma risk prediction modelsQ41639663
Development of a targeted risk-group model for skin cancer screening based on more than 100,000 total skin examinationsQ42484750
Predicting melanoma risk for the Australian populationQ44280187
Identifying individuals at high risk of melanoma: a practical predictor of absolute riskQ44986625
Adjuvant Nivolumab versus Ipilimumab in Resected Stage III or IV MelanomaQ47551890
Melanoma staging: Evidence-based changes in the American Joint Committee on Cancer eighth edition cancer staging manualQ47803820
Adjuvant Dabrafenib plus Trametinib in Stage III BRAF-Mutated Melanoma.Q47824495
Overall Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma.Q47826637
Identifying individuals at high risk of melanoma: a simple tool.Q53708923
Risk Factors and Individual Probabilities of Melanoma for WhitesQ57749811
P433issue23
P407language of work or nameEnglishQ1860
P304page(s)4145-4156
P577publication date2018-12-01
P1433published inHuman Molecular GeneticsQ2720965
P1476titleCombining common genetic variants and non-genetic risk factors to predict risk of cutaneous melanoma
P478volume27

Reverse relations

Q91584550Interleukin 1 receptor antagonist gene variable number of tandem repeats polymorphism and cutaneous melanomacites workP2860

Search more.